High-sensitive troponin-T in adult congenital heart disease

Jannet A Eindhoven1, Jolien W Roos-Hesselink1, Annemien E van den Bosch1

  • 1Department of cardiology, Thorax Center, Erasmus MC, Rotterdam, The Netherlands.

Insights

Elevated high-sensitive troponin-T (hs-TnT) levels are common in adult congenital heart disease (ACHD) patients, particularly those with systemic right ventricle or pulmonary hypertension. This finding suggests hs-TnT may be a valuable prognostic marker in ACHD.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Adult Congenital Heart Disease

Background:

  • Adult congenital heart disease (ACHD) patients face risks of arrhythmias, heart failure, and sudden death.
  • High-sensitive troponin-T (hs-TnT) is standard for acute coronary syndrome but also indicates cardiac function and prognosis in other heart conditions.

Purpose of the Study:

  • To determine hs-TnT levels in ACHD patients.
  • To explore the relationship between hs-TnT, cardiac function, and other biomarkers in ACHD.

Main Methods:

  • Consecutive ACHD outpatients underwent same-day echocardiography, exercise testing, and venipuncture.
  • hs-TnT levels were measured and analyzed in relation to clinical parameters.

Main Results:

  • 41% of 587 ACHD patients had detectable hs-TnT; 8% exceeded the 99th percentile (14 ng/L).
  • Elevated hs-TnT was associated with systemic RV, pulmonary hypertension, older age, NYHA class II+, systolic dysfunction, and non-sinus rhythm.
  • hs-TnT correlated significantly with NT-proBNP (r=0.400, p<0.001).

Conclusions:

  • A significant proportion of stable ACHD patients exhibit hs-TnT levels above the 99th percentile.
  • Elevated hs-TnT is linked to specific conditions like systemic RV and pulmonary hypertension.
  • hs-TnT's correlation with NT-proBNP and ventricular function suggests promising predictive value in ACHD, warranting further research.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
629